Author

E. M. Hodel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Organism:human· 1 Assay:metagenomics· 1 Organism:virus· 1

Frequent Co-Authors

I. Hastings· 2 shared K. Kay· 2 shared A. Lerch· 1 shared I. Felger· 1 shared K. B. Hong· 1 shared M. Gruenberg· 1 shared S. Jones· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

I. Hastings

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivMar 23, 2021

Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials?

S. Jones, K. Kay, E. M. Hodel…·I. Hastings

This paper evaluates deep sequenced amplicons (AmpSeq) as a method for molecular correction in malaria drug trials, finding it improves drug failure rate detection compared to current methods.

DOI 10.1128/aac.00437-21

virusmetagenomics

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintMar 14, 2019

Evaluating artesunate-amodiaquine deployment, efficacy and safety: an in silico pharmacological model

K. B. Hong, I. Hastings, K. Kay, E. M. Hodel

This study uses a pharmacological model to compare the efficacy, effectiveness, and safety of AS-AQ fixed dose combination and non-fixed formulations in different treatment scenarios.

DOI 10.1101/567008

humanstatistical model

𝕏 PostBluesky